The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial.
Liumei ShouTianyu ShaoJialu ChenYao ZhangQi-Jin ShuPublished in: Integrative cancer therapies (2023)
Chinese Clinical Trial Registry, ChiCTR1900027518. Registered on 17 Nov 2019.